Harvard endowment declines on flat returns

In a year of flat investment returns, the endowment declines as distributions support Harvard University operations

Harvard’s endowment was valued at $30.7 billion last June 30, the end of fiscal year 2012—a decline of $1.3 billion (4.1 percent) from the prior year. That result, released September 26 in Harvard Management Company’s (HMC) annual report, reflects an investment return of -0.05 percent on endowment and related assets, following the robust return of 21.4 percent in fiscal 2011. The decline in the endowment’s value reflects the investment return (essentially nil); minus distribution of endowment funds to support University operations and for other purposes (perhaps $1.5 billion; the exact sum will be reported in late October); plus gifts received. Endowment distributions account for about one-third of Harvard’s annual revenues.

Domestic equities yielded a return of 9.65 percent, but international stocks declined sharply, producing an overall return of -6.66 percent for public equities—about one-third of the invested assets. Private equities and absolute-return assets (principally hedge funds)—together, about 30 percent of assets—yielded slightly positive returns. Fixed-income holdings (about 10 percent of the total) yielded 7.95 percent. Real assets were mixed, with strong gains in real estate, positive returns in natural resources (timber- and farmland), and significant losses in the commodities portfolio.

Peer institutions’ results demonstrated the important interplay of endowment investment returns, spending, and gifts from capital campaigns. At Yale, a 4.7 percent investment return for fiscal 2012 nearly offset distributions of about $1 billion, so the endowment declined only marginally during the year, from $19.4 billion to $19.3 billion. Stanford’s investments earned only 1 percent, but the endowment rose 3.2 percent in value, to $17 billion, as a surge of campaign gifts apparently more than offset nearly $900 million in spending.

HMC president and CEO Jane L. Mendillo cautioned that “at a time of unusual turbulence with significant macroeconomic issues facings regions around the world…future returns may be uncertain,” but expressed confidence in a strategy of focusing on highly diversified investments and “long-term value creation.”

For a detailed report on Harvard’s endowment performance, see https://harvardmag.com/endowment-12.

You might also like

Harvard Students, Alumna Named Rhodes and Marshall Scholars

Nine Rhodes and five Marshall scholars will study in the U.K. in 2026.

Five Questions with Michèle Duguay

A Harvard scholar of music theory on how streaming services have changed the experience of music

Harvard Faculty Discuss Tenure Denials

New data show a shift in when, in the process, rejections occur

Most popular

Harvard Revamps Controversial Public Health School Center

The health and human rights center had drawn attention for its Palestine-related program.

Getting to Mars (for Real)

Humans have been dreaming of living on the Red Planet for decades. Harvard researchers are on the case.

Explore More From Current Issue

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.